BMI, Health Conditions & Eligibility Not sure if you qualify
It has been found to be helpful in the treatment of conditions like Parkinson's disease, Alzheimer's disease, and multiple sclerosis, where oxidative stress plays a role
Most are gastrointestinal and usually mild: Nausea (often improves after 24 weeks) Diarrhea or constipation Bloating or abdominal discomfort Reduced appetite (that one's the point) Fatigue in the first few weeks To minimize them: follow the titration schedule, eat smaller meals, go easy on greasy/high-fat foods, stay hydrated, and consider injecting at bedtime
We may include supporting documentation such as: Documented adverse reactions to Wegovy Co-existing conditions like obstructive sleep apnea (OSA) Evidence of significant progress, such as 5% or more weight loss on Zepbound (tirzepatide) Step 2: If the first prior authorization appeal is approved, CVS Caremark is currently covering Mounjaro (tirzepatide) even for patients without Type 2 diabetes
Yes, older adults, those taking diuretic medications, people with kidney disease, and individuals with physically demanding jobs or who exercise intensely may have increased risk